Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Rotavirus VP7 glycoprotein** is a highly conserved structural protein forming the outermost layer of the rotavirus capsid[4][8]. It is a trimeric, calcium ion–stabilized glycoprotein synthesized and processed in the endoplasmic reticulum, where it is essential for virion assembly and stability[1][4]. VP7 is the principal target of neutralizing antibodies, making it a primary determinant of rotavirus G serotypes and a critical antigen for vaccine development[3][5][6]. Removal of Ca2+ ions destabilizes the VP7 trimer and initiates viral entry by promoting uncoating[3][5]. VP7 contains multiple neutralizing epitopes and is subject to antigenic variation, with its gene (segment 9) used for molecular classification of rotavirus strains[4][6]. The protein's proper folding and function require glycosylation and correct disulfide bond formation[7]. VP7-directed immune responses are central to both natural immunity and vaccine-mediated protection against rotavirus infection[3][6].
Neutralization: Antibodies stabilize the VP7 trimer, inhibiting uncoating and viral entry[3][5]. Induction of protective immunity: Subunit or inactivated vaccines based on VP7 elicit neutralizing antibodies[3].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus VP7 glycoprotein (VP7).